PX Biosolutions is a biotech company developing a novel vaccine adjuvant platform technology, DCtag, with prophylactic and therapeutic utility in both human and animal applications.
Tag Archives: dendritic cells
CiMaas – cellular immonotherapy
CiMaas BV is a biotech company developing cellular immunotherapy for specific groups of cancer patients. CiMaas focuses on the development of two unique products: a cancer vaccine using the patient’s own immune (dendritic) cells and the production of donor natural killer cells. These methods can help to treat many oncological diseases.
CiMaas – cellular immonotherapy
Bellicum – dendritic cell vaccines
Bellicum Pharmaceuticals is a biopharma company developing novel cellular immunotherapies for various forms of cancer (both hematological and solid tumors), as well as orphan inherited blood disorders.
Bellicum – dendritic cell vaccines
Cellin Technologies – cell therapy products
Cellin Technologies is a cell therapy products contract manufacturing company developing proprietary technologies to produce cells for experimental or clinical applications. Cellin Technologies provides services to biopharma and biotech companies, both in Estonia and external markets.
